In colorectal cancer cells PF-543, a novel sphingosine kinase 1 (SphK1) inhibitor, provoked programmed necrosis by inducing MMP reduction and mitochondrial p53-CyPD complexation49. Here, TP53 is linked to colorectal cancer.